Search results
Results from the WOW.Com Content Network
Acinic cell carcinoma is a malignant tumor representing 2% of all salivary tumors. 90% of the time found in the parotid gland, 10% intraorally on buccal mucosa or palate. The disease presents as a slow growing mass, associated with pain or tenderness in 50% of the cases.
At least focal preservation of the basal cell layer [11] PSA+ [10] AMACR+ [10] Basal cell markers+ [10] Urothelial carcinoma 0.7 to 2.8% [12] Umbrella cells are usually present in low-grade tumors [13] Frequently branching fibrovascular cores [13] Frequently fusing of papillae [13] Not recommended [1] Small-cell carcinoma 0.3–2% [14] [15 ...
Acinar adenocarcinoma of the lung is a highly lethal disease. Overall, the five-year survival rates approximate 16% to 22%. Generally, survival is better in all stages for patients with the acinar (or papillary) pattern than it is in patients with the solid pattern, but considerably worse than those with the bronchioloalveolar pattern.
Print/export Download as PDF; Printable version; In other projects Wikidata item; ... M8550/3 Acinar cell carcinoma Acinic cell adenocarcinoma;
Acinic cell carcinoma of the lung is a very uncommon tumor that typically appears close to the right bronchus. [1] As of 2022, only 29 cases have been documented in the English literature [ 1 ] since Fechner et al. first described this entity in 1972. [ 2 ]
The antibody cocktail binds to cytokeratin 1 - 8, 10, 14 - 16 and 19 (but not CK17 or CK18). [1] It is therefore used as a marker of carcinomas, such as depth of invasion and metastases. [1]
CT scan in a patient with acinar cell carcinoma. The disease is more common in men than women and the average age at diagnosis is about 60. [2] Symptoms are often non-specific and include weight loss. A classic presentation, found in around 15% of cases includes subcutaneous nodules (due to fat necrosis) and arthralgias, caused by a release of ...
In urologic pathology, atypical small acinar proliferation, is a collection of small prostatic glands, on prostate biopsy, whose significance is uncertain and cannot be determined to be benign or malignant.